Cancer

Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact

Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact

14 hours ago   |   Xconomy

With the year's biggest oncology conference days away, Gilead Sciences is signaling now what its cancer immunotherapy pipeline could look like in the years to come. The drug...
Read more ...

Comprehensive profiling of circRNAs and the tumor suppressor function of circHIPK3 in clear cell renal carcinoma

19 hours ago   |   Springer

Abstract Increasing evidence has indicated that circular RNAs play a key role in the development and progression of diverse cancers, but their role in clear cell renal...
Read more ...

How a protein can inhibit cancer development in mice

1 day ago   |   ScienceDaily

In a new study, researchers have discovered how the protein PP2A can inhibit tumor growth in mice. The protein turns off an enzyme that stimulates cell growth, thus inhibiting...
Read more ...

Sugars that coat proteins are a possible drug target for pancreatitis

1 day ago   |   San Diego Biotechnology

LA JOLLA-Pancreatitis is an inflammation of the pancreas that accounts for 275,000 hospitalizations in the United States annually. Patients who suffer from hereditary...
Read more ...

Assessment of telomerase as drug target in breast cancer

1 day ago   |   Journal of Biosciences

Abstract Telomerase is a specialized enzyme which maintains telomere length at the extreme end of the chromosome. Over 90% of all cases of cancer show high expression of...
Read more ...

Data at 2020 ASCO Virtual Scientific Program Demonstrates Strength of Nucleix's Six-Marker Methylation-Based Assay Detecting Broad Array of Early Cancers

1 day ago   |   San Diego Biotechnology

SAN DIEGO & REHOVOT, Israel--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that it will present data from...
Read more ...

Yes to local NO

3 days ago   |   ACS Division of Biological Chemistry   |   7 articles

Nature Chemical Biology, Published online: 22 May 2020; doi:10.1038/s41589-020-0552-7 A pair of fluorescent indicator-tagged DNA-duplex scaffolds permit assessments of nitric...
Read more ...

Poly /poly core-shell nanofibers loaded by multi-walled carbon nanotubes and 5-fluorouracil: an anticancer drug delivery system

4 days ago   |   Springer

Abstract Cancer is one of the most fatal diseases in the world. Chemotherapy and radiation therapy are conventional cancer treatments affecting healthy tissues and also have...
Read more ...

Postdoctoral Fellow - Cancer Targets and New Drug Discovery - Sanford Burnham Prebys Medical Discovery Institute - La Jolla, CA

5 days ago   |   San Diego Biotechnology

The goal of this 2-year training program is to establish an innovative multi-thematic graduate student and postdoctoral training program to train the next...From Sanford...
Read more ...

UFGI publication round-up week 3/2/20

5 days ago   |   Genetics Institute   |   6 articles

Predator-induced stress responses in insects: A review. Cinel SD, Hahn DA, Kawahara AY. J Insect Physiol. 2020 Feb 27;122:104039. doi: 10.1016/j.jinsphys.2020.104039...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

AbCellera Raises $105M to Advance Antibody Discovery Operations

AbCellera Raises $105M to Advance Antibody Discovery Operations

Most of the best-selling drugs worldwide today are antibodies, and in the three decades-plus since the first such drug was approved, makers of such treatments have begun... Read more ...

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From...

New webinars: Simple Signaling Reporter Assays & Reducing Attrition From Drug-induced Liver Injury

Xconomy Insight is excited to offer two special webinars to our community this June. Sponsored by Eurofins, registration is free to all. Screening Approaches for Reducing... Read more ...

Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact

Gilead Gains Foothold in Solid Tumors With $375M, 10-Year Arcus Bio Pact

With the year's biggest oncology conference days away, Gilead Sciences is signaling now what its cancer immunotherapy pipeline could look like in the years to come. The drug... Read more ...

Unanswered Questions Drive Convalescent Plasma Research

Unanswered Questions Drive Convalescent Plasma Research

On Saturday, March 14, in southwest Wisconsin, a woman was working in her yard, raking and clearing the first spring weeds. She coughed a bit during the day, and felt some... Read more ...

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck Outlines COVID-19 Ambitions With Buyout Deal, Collaborations

Merck exited the holiday weekend with some fireworks of its own, announcing three major programs on Tuesday all related to investments in finding ways to treat and prevent... Read more ...

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

Insitro Adds $143M to Fuel Machine Learning-Driven Drug Development

A stem cell biologist, a gene editing expert, and a data engineer walk into a room...and that's just a few of the people Daphne Koller has recruited in the past two years to... Read more ...

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

Site of LUX-ZEPLIN Dark Matter Search Project Carefully Ramps Up Science Work

A photomultiplier tube array that is part of the LUX-ZEPLIN experiment at the Sanford Underground Research Facility in Lead, South Dakota. The photomultiplier tubes are... Read more ...

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Viacyte Adds $27M to Move Ahead Trio of Stem Cell Diabetes Treatments

Privately held biotech ViaCyte has banked $27 million, the majority an installment of cash from a tranched $80 million Series D financing round it closed in late 2018. The... Read more ...

COVID-19 Sparks New Opportunities for Digital Health Companies

COVID-19 Sparks New Opportunities for Digital Health Companies

Clinicians and regulators are rethinking how healthcare is provided amid precautions prompted by COVID-19. In-person physician visits don't fit within the physical distancing... Read more ...

AveXis Inc.: Business Systems Analyst

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...